Dr. Kathleen I. Pritchard, MD, F. R.C.P.(C)

Directeur de la recherche clinique et épidemiologie du Toronto Sunnybrook Regional Cancer Center

Professeur du département de médecine santé publique et sciences, Université de Toronto

« Le programme "Passion pour la vie " d’Antoine Gaber est une merveilleuse initiative, il a travaillé dans le domaine de la recherche sur le cancer du sein durant plusieurs années contribuant au développement d’une variété de médicaments pour le traitement du cancer du sein, et maintenant il utilise son talent artistique internationalement reconnu pour aider à amasser des fonds pour la recherche contre le cancer et pour conscientiser toujours davantage à la maladie. »

Ayant travaillé dans le domaine pendant toutes ces années, Antoine Gaber a développé une passion pour la vie et pour le bien-être des patients qui se reflète non seulement dans sa recherche clinique et dans son art, mais aussi à travers les causes philanthropiques qu'il supporte. La vision et la détermination d'Antoine Gaber ont toujours été guidées par le désir de faire un monde où il fait mieux vivre» a indiqué Dr. Kathleen Pritchard, spécialiste du cancer du sein de renommée internationale au centre du cancer de Sunnybrook à Toronto au Canada.

"Cosmolane, the distributor of Orlane Paris in Canada, a French cosmetic company, who is supporting Gaber's " Passion for Life" program with the Bay stores identified new innovative way while fundraising for the breast cancer research promoting their high quality beauty products.

"Cosmolane / Orlane Paris is a young Canadian Corporation who is innovative in finding new ways of promoting very good cosmetic products for which some of them have gone through clinical research, but also very oriented in supporting women's issues such as Breast Cancer research", said Professor Kathleen Pritchard.

" Passion pour la vie " Communiqué de presse video (B-Roll) Questions / réponses: (disponible seulement en version anglaise)

Que pensez-vous de l'initiative « Passion pour la vie » du peintre Antoine Gaber afin de venir en aide à l'Alliance canadienne de recherche contre le cancer du sein ?

Antoine Gaber's " Passion for Life" initiative is amazing, he has worked in Breast Cancer Research for many years contributing to the development of several breast cancer drugs, and now he is using his internationally recognized artistic talent to contribute to raise money for cancer research and awareness.

Que pensez-vous de Cosmolane, le distributeur de la compagnie Orlane Paris, qui supporte cette promotion « Passion pour la vie » ?

Cosmolane / Orlane Paris is a young Canadian Corporation who is innovative in finding new ways of promoting very good cosmetic products for which some of them have gone through clinical research, but also very oriented in supporting women's issues such as Breast Cancer research.

Quel lien voyez-vous entre les produits de beauté Orlane Paris, Antoine Gaber et l'Alliance canadienne de recherche contre le cancer du sein à travers l'initiative « Passion pour la vie » ?

Orlane products link beauty, soul and women's concerns. Beauty through the use of Orlane quality products offering women to look at they're best and feeling good about themselves. Antoine Gaber impressionist artwork provides a universe of internal peace and silence for the soul while contributing to an important cause, breast cancer research.

BIOGRAPHIE: (disponible seulement en version anglaise)

Dr. Pritchard is one of Sunnybrook & Women's best-known academic physicians. Dr. Pritchard graduated from Science (BA (Sci) 1968), and Medicine (M.D. 1971) at Queen's University in Kingston, Ontario, Canada. She trained in Internal Medicine in the University of Toronto Program in General Internal Medicine for three years, at the Wellesley Hospital, the Toronto Western Hospital, and the Toronto General Hospital. She then entered Medical Oncology, spending two years in the University of Toronto Program (Princess Margaret Hospital), and two years as a Research Fellow, first in tumour immunology and melanoma (1973-1974); and subsequently in the area of clinical trials in breast cancer.

Dr. Pritchard joined the staff of the University of Toronto at Women's College Hospital in 1978, and was appointed Head, Medical Oncology and Haematology there in 1984. She was supported for her work in Clinical Trials Research through a Career Award as a Clinical Trials Scholar from the National Cancer Institute of Canada (NCIC) from 1978 to 1984. In 1984, she was named Chair of the Breast Cancer Site Group of the NCIC Clinical Trials Group and has served in that role, or as Co-chair, up until the present time.

In 1987, Dr. Pritchard moved to the Toronto-Sunnybrook Regional Cancer Centre (TSRCC) as Head of Medical Oncology (subsequently Medical Oncology and Haematology) and in 1997 was also appointed Head, Clinical Trials and Epidemiology at TSRCC. She has served as Chair and Cochair of the Breast Cancer Site Group of the Ontario Practice Guidelines Initiative from 1990 through 2002, and in 1998, was also appointed as Clinical Director of the Ontario Clinical Oncology Group. Dr. Pritchard was a founding member of the Canadian Oncology Society (1978) and subsequently their Vice-President (1992-1994). She was also a Founding Member of the Canadian Association of Medical Oncology (1988), and their second President (1990-1992).

Dr. Pritchard has also served as Chair of the Management Committee of the Canadian Breast Cancer Research Initiative, a partnership which funds much of the breast cancer research done across Canada (1999-2002). She currently serves on the Editorial Board of the Journal of Clinical Oncology, Current Oncology, Clinical Breast Cancer, and Medscape (Oncology and Women's Health). Dr. Pritchard's interests in clinical trials in breast cancer, in the career development of oncologists, and in the establishment of practice guidelines is demonstrated by these activities, and by her over 250 publications, and many invited lectures across Canada, North America, and Internationally.

Dr. Pritchard's major areas of interest include:

· Multicentre clinical trials; design, conduct and analysis
· Adjuvant therapy for breast cancer
· Correlative and translational research in breast cancer
· Tumour tissue data banking
· Predictive and prognostic factors in breast cancer
· Hormonal therapy for breast cancer
· Menopausal symptoms and their effect on quality of life in women with a diagnosis of breast cancer.
· The role of hormone replacement therapy in women with a diagnosis of breast cancer